Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Medpace Holdings, Inc. | medp-ex321_9.htm |
| EX-31.2 - EX-31.2 - Medpace Holdings, Inc. | medp-ex312_8.htm |
| EX-31.1 - EX-31.1 - Medpace Holdings, Inc. | medp-ex311_7.htm |
| 10-Q - 10-Q - Medpace Holdings, Inc. | medp-10q_20170630.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Medpace Holdings, Inc. (the “Company”) on Form 10-Q for the quarter ended June 30, 2017 filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jesse Geiger, Chief Financial Officer and Chief Operating Officer, Laboratory Operations of the Company, do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
|
|
• |
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
|
• |
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the periods presented therein. |
Date: August 1, 2017
|
By: |
|
/s/ Jesse Geiger |
|
|
|
Jesse Geiger |
|
|
|
Chief Financial Officer and Chief Operating Officer, Laboratory Operations |
|
|
|
(Principal Financial Officer) |